[144] KLA Corporation SEC Filing

Rhea-AI Filing Summary

KLA Corporation (KLAC) filed a Form 144 proposing the sale of 8,049 common shares, submitted for sale through Fidelity Brokerage Services LLC on NASDAQ with an aggregate market value of $7,354,210.32 and an approximate sale date of 08/12/2025. The filing lists the issuer's total shares outstanding as 131,961,370. The shares to be sold were acquired through a mix of restricted stock vesting and an employee stock purchase plan (ESPP) on dates between March 20, 2024 and August 7, 2025, with specific lot sizes disclosed in the table. The filer reports Nothing to Report for securities sold during the past three months and includes the standard representation that the signer does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider filed to sell 8,049 KLAC shares worth $7.35M; acquisition sources and sale logistics are disclosed.

The Form 144 documents a proposed brokered sale of 8,049 common shares via Fidelity with an aggregate market value of $7,354,210.32 and an approximate sale date of 08/12/2025. The filing explicitly lists acquisition details: restricted stock vesting and an ESPP purchase across several dates (03/20/2024 through 08/07/2025) and indicates no insider sales in the prior three months. For investors, the filing is a routine disclosure of an intended sale rather than a transaction showing completed transfers; it provides transparency on lot origins and gross value.

Corporate Governance Expert

TL;DR: Governance disclosure included; filer attests no undisclosed material adverse information and acquisition lots are clearly itemized.

The filing contains the standard attestation that the person for whose account the securities will be sold does not know of any undisclosed material adverse information. The form lists multiple compensatory vesting events and one ESPP purchase as the sources of the shares and names the executing broker as Fidelity Brokerage Services LLC. The field for plan adoption or Rule 10b5-1 instruction date appears unpopulated in the provided content, so no explicit 10b5-1 plan date is disclosed. Overall, the document provides customary insider-sale transparency without additional governance disclosures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8049	7354210.32	131961370	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/20/2024	Restricted Stock Vesting	Issuer			3434	03/20/2024	Compensation
Common	06/30/2025	ESPP Purchase	Issuer			39	06/30/2025	Cash
Common	06/30/2025	Restricted Stock Vesting	Issuer			1146	06/30/2025	Compensation
Common	08/01/2025	Restricted Stock Vesting	Issuer			305	08/01/2025	Compensation
Common	08/04/2025	Restricted Stock Vesting	Issuer			708	08/04/2025	Compensation
Common	08/05/2025	Restricted Stock Vesting	Issuer			1290	08/05/2025	Compensation
Common	08/07/2025	Restricted Stock Vesting	Issuer			1127	08/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the KLAC Form 144 report?

The filing reports a proposed sale of 8,049 common shares with an aggregate market value of $7,354,210.32, to be executed on or about 08/12/2025 on NASDAQ.

Who is the broker handling the proposed sale in the KLAC Form 144?

The broker named is Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI 02917.

How were the securities to be sold acquired according to the filing?

The securities were acquired via restricted stock vesting (multiple dates) and an ESPP purchase (06/30/2025), with specific lot sizes shown in the table (for example, 3,434 from 03/20/2024 vesting, 39 from ESPP on 06/30/2025).

Were any KLAC securities sold by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the Form 144 indicate reliance on a Rule 10b5-1 trading plan?

The filing includes the field for a plan adoption or instruction date but no date is provided in the content, so no 10b5-1 plan date is disclosed in the provided form.